Services Sector Most Volatile: Zulily Inc. (NASDAQ:ZU), AirMedia (NASDAQ:AMCN), E Commerce China Dangdang (NYSE:DANG), Inuvo (NYSEMKT:INUV)

Zulily (NYSE:ZU) stock had its “sector perform” rating reaffirmed by research analysts at RBC Capital in a report released on Tuesday, Analyst Ratings.Net reports. They currently have a $40.00 price objective on the stock, down from their previous price objective of $50.00. RBC Capital’s price objective would indicate a potential downside of 35.05% from the stock’s previous close. Zulily Inc. (NASDAQ:ZU) stock performance was -2.72% … Continue reading Services Sector Most Volatile: Zulily Inc. (NASDAQ:ZU), AirMedia (NASDAQ:AMCN), E Commerce China Dangdang (NYSE:DANG), Inuvo (NYSEMKT:INUV)

Biotech Stocks Touching New Lows: Reliv International (NASDAQ:RELV), Can Fite Biopharma (NYSEMKT:CANF), Enzymotec (NASDAQ:ENZY), Pacific Biosciences (NASDAQ:PACB)

An increase in European and U.S. sales helped Reliv International Inc. (NASDAQ:RELV) raise profits by a small amount in the fourth quarter. Reliv International, Inc (NASDAQ:RELV) stock performance was -11.60% in last session and finished the day at $2.03. Traded volume was 64,448.00million shares in the last session and the average volume of the stock remained 10.29K shares. The beta of the stock remained 1.35. … Continue reading Biotech Stocks Touching New Lows: Reliv International (NASDAQ:RELV), Can Fite Biopharma (NYSEMKT:CANF), Enzymotec (NASDAQ:ENZY), Pacific Biosciences (NASDAQ:PACB)

Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) on Mar. 3 announced the appointment of Mark P. Carthy to the company’s Board of Directors. Mr. Carthy is the Managing Partner of Orion Equity Partners, LLC, a healthcare venture capital management and advisory firm co-founded by Mr. Carthy in 2008. Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) stock performance was -5.68% in last session and finished the day at $1.25. Traded volume was … Continue reading Biotech Top Losers: Rexahn Pharmaceuticals (NYSEMKT:RNN), Aegerion Pharmaceuticals (NASDAQ:AEGR), Enzymotec Ltd (NASDAQ:ENZY), Can Fite Biopharma (NYSEMKT:CANF)

Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) was a big mover last session, as its shares rose nearly 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the trend for the healthcare company since Feb 24, as the stock is now down nearly 19%. Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) dropped -5.53 percent to $52.46 … Continue reading Biotech Top Losers: Rexahn Pharmaceuticals (NYSEMKT:RNN), Aegerion Pharmaceuticals (NASDAQ:AEGR), Enzymotec Ltd (NASDAQ:ENZY), Can Fite Biopharma (NYSEMKT:CANF)

The U.S. Justice Department said on Monday that American Airlines Group made $425 million by selling take-off and landing slots at two busy East Coast airports, as required to win approval for the merger that set up the company. American Airlines Group Inc. (NASDAQ:AAL) stock performance was -0.15% in last session and finished the day at $38.96. Traded volume was 11.42 million shares in the … Continue reading Services Sector Stocks Touching New Highs: American Airlines Group (NASDAQ:AAL), Southwest Airlines (NYSE:LUV), McClatchy (NYSE:MNI), United Rentals (NYSE:URI)

CRT Capital Thursday morning ratings report included a coverage initiation by analyst Arlinda Lee on Oncogenex Pharmaceuticals (NASDAQ: OGXI) with a Buy rating and price target of $20. OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) rose 8.88 percent to $13.85 yesterday on volume of 483,342million shares. The intra-day range of the stock was $12.61 to $13.95. OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) has a market capitalization of $203.70million. Emergent Biosolutions … Continue reading Biotech Stocks Touching New Highs: Northwest Biotherapeutics (NASDAQ:NWBO), OncoGenex Pharmaceuticals (NASDAQ:OGXI), Emergent Biosolutions (NYSE:EBS), Xencor (NASDAQ:XNCR)